Advertisements



We are Sorry, This Page doesn't Exist


Exelixis announces "positive" final data for Phase 1 cabozantinib trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2021

CHF Solutions announces discussion on UF in heart failure patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytJan 28th, 2021

BioMarin"s stock tumbles 6% after sharing data about experimental hemophilia A drug

Shares of BioMarin Pharmaceuticals Inc. tumbled 6.6% in trading on Monday, the day after the company shared positive findings from a.....»»

Category: topSource: marketwatchJan 11th, 2021

Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

Category: topSource: marketwatchJan 11th, 2021

Theratechnologies announces new data for investigational peptide-drug conjugates

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2020

Dow soars 530 points as coronavirus treatment optimism overshadows GDP slump

Andrew Burton/Getty Images US equities soared on Wednesday as traders gained new hope from positive preliminary data from a coronavirus drug trial. Gilead said on Wednesday morning that its remdesivir compound succee.....»»

Category: topSource: businessinsiderApr 29th, 2020

Shares jump after upbeat coronavirus drug data, oil surges

World stock markets surged on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged......»»

Category: topSource: reutersApr 29th, 2020

Gilead reports early positive data in remdesivir studies as COVID-19 drug, though Chinese trial sees no benefit

Gilead Sciences Inc.’s experimental dr.....»»

Category: topSource: marketwatchApr 29th, 2020

Gilead reports positive data in trial of possible virus drug

Gilead Sciences s.....»»

Category: topSource: moneycentralApr 29th, 2020

Gilead reports positive data in trial of possible virus drug

Gilead Sciences s.....»»

Category: topSource: moneycentralApr 29th, 2020

Shares gain after encouraging COVID-19 drug data, oil jumps

A gauge of global stocks climbed on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged......»»

Category: topSource: reutersApr 29th, 2020

This Company Made Back Pain Therapies. Now It"s Out For A COVID-19 Drug.

Last week, Mesoblast Limited (NASDAQ: MESO) was plugging away at therapies for heart failure, chronic back pain and rheumatoid arthritis. This week, it’s tackling the pandemic. read more.....»»

Category: blogSource: benzingaMar 20th, 2020

AnaptysBio Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Pipeline Updates

Interim Top-Line Data From Etokimab ECLIPSE Phase 2 Trial in Chronic Rhinosinusitis with Nasal Polyps Anticipated in First Half of 2020    Reported Positive Topline Data .....»»

Category: earningsSource: benzingaMar 2nd, 2020

Tandem Diabetes announces "positive data" presented at ATTD meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2020

Brickell Biotech Soars On Publication Of Positive Midstage Data For Hyperhidrosis Drug

Shares of thinly traded nano-cap biotech Brickell Biotech Inc (NASDAQ: BBI) are skyrocketing on above-average volume Thursday. read more.....»»

Category: blogSource: benzingaFeb 20th, 2020

Acceleron Hits All-Time High On Positive Readout For Pulmonary Arterial Hypertension Drug

Shares of small-cap biopharma Acceleron Pharma Inc (NASDAQ: XLRN) are advancing to an all-time high Tuesday following a data readout. Latest Ratings for XL.....»»

Category: blogSource: benzingaJan 28th, 2020

GlaxoSmithKline CEO expects to get "at least" six drug approvals from the FDA in 2020

GlaxoSmithKline CEO Emma Walmsley told "Mad Money" host Jim Cramer the British drugmaker has received "positive data" for cancer and HIV drugs......»»

Category: topSource: madmoneyJan 13th, 2020

The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck"s Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biot.....»»

Category: earningsSource: benzingaJan 7th, 2020

Teligent announces FDA request for further data on complex drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 23rd, 2019

Sage drug still differentiated despite positive Axsome data, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 16th, 2019